In the majority of OSCC cases, epidermal growth factor receptor (EGFR) association (EGFR / ErB1 / HER1) has been reported to encourage aggressiveness, metastases, poor prognosis and resistance to anticancer therapy [7].This is expressed in a variety of other cancers. The gene discussed is EGFR; the disease is cancer.